Combinatorial Discovery of Defined Substrates That Promote a Stem Cell State in Malignant Melanoma

The tumor microenvironment is implicated in orchestrating cancer cell transformation and metastasis. However, specific cell–ligand interactions between cancer cells and the extracellular matrix are difficult to decipher due to a dynamic and multivariate presentation of many signaling molecules. Here we report a versatile peptide microarray platform that is capable of screening for cancer cell phenotypic changes in response to ligand–receptor interactions. Using a screen of 78 peptide combinations derived from proteins present in the melanoma microenvironment, we identify a proteoglycan binding and bone morphogenic protein 7 (BMP7) derived sequence that selectively promotes the expression of several putative melanoma initiating cell markers. We characterize signaling associated with each of these peptides in the activation of melanoma pro-tumorigenic signaling and reveal a role for proteoglycan mediated adhesion and signaling through Smad 2/3. A defined substratum that controls the state of malignant melanoma may prove useful in spatially normalizing a heterogeneous population of tumor cells for discovery of therapeutics that target a specific state and for identifying new drug targets and reagents for intervention.

[1]  Alexander Roesch,et al.  A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth , 2010, Cell.

[2]  A. Pinto,et al.  Bone morphogenetic protein-7 induces telomerase inhibition, telomere shortening, breast cancer cell senescence, and death via Smad3. , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  T. Murohara,et al.  Pitavastatin-induced angiogenesis and arteriogenesis is mediated by Notch1 in a murine hindlimb ischemia model without induction of VEGF , 2011, Laboratory Investigation.

[4]  Douglas Zhang,et al.  Peptide microarrays for the discovery of bioactive surfaces that guide cellular processes: a single step azide-alkyne "click" chemistry approach. , 2014, Journal of materials chemistry. B.

[5]  M. Hendrix,et al.  A Three‐Dimensional Model to Study the Epigenetic Effects Induced by the Microenvironment of Human Embryonic Stem Cells , 2006, Stem cells.

[6]  W. Murphy,et al.  Modular peptide growth factors for substrate-mediated stem cell differentiation. , 2009, Angewandte Chemie.

[7]  H. Krutzsch,et al.  Heparin- and sulfatide-binding peptides from the type I repeats of human thrombospondin promote melanoma cell adhesion. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Mrksich,et al.  Detection of Differentially Expressed Basal Cell Proteins by Mass Spectrometry* , 2009, Molecular & Cellular Proteomics.

[9]  Thomas J Webster,et al.  Increased osteoblast functions in the presence of BMP-7 short peptides for nanostructured biomaterial applications. , 2009, Journal of biomedical materials research. Part A.

[10]  Junmin Lee,et al.  Cell shape and the presentation of adhesion ligands guide smooth muscle myogenesis. , 2016, Journal of biomedical materials research. Part A.

[11]  Max S Wicha,et al.  Breast cancer stem cells, cytokine networks, and the tumor microenvironment. , 2011, The Journal of clinical investigation.

[12]  M. Hendrix,et al.  Influence of the microenvironment on melanoma cell fate determination and phenotype. , 2006, Cancer research.

[13]  J. Massagué.  TGF-beta signal transduction. , 1998, Annual review of biochemistry.

[14]  Junmin Lee,et al.  Interfacial geometry dictates cancer cell tumorigenicity. , 2016, Nature materials.

[15]  Yukihide Iwamoto,et al.  Identification of an amino acid sequence in laminin mediating cell attachment, chemotaxis, and receptor binding , 1987, Cell.

[16]  Kenneth M. Yamada,et al.  Integrin transmembrane signaling and cytoskeletal control. , 1995, Current opinion in cell biology.

[17]  P. Gimotty,et al.  Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation , 2012, Oncogene.

[18]  M. Allen,et al.  Jekyll and Hyde: the role of the microenvironment on the progression of cancer , 2011, The Journal of pathology.

[19]  C. Chung,et al.  Osteoblastic differentiation of human bone marrow stromal cells in self-assembled BMP-2 receptor-binding peptide-amphiphiles. , 2009, Biomaterials.

[20]  S. Morrison,et al.  Efficient tumor formation by single human melanoma cells , 2008, Nature.

[21]  K E Healy,et al.  Biomimetic Peptide Surfaces That Regulate Adhesion, Spreading, Cytoskeletal Organization, and Mineralization of the Matrix Deposited by Osteoblast‐like Cells , 1999, Biotechnology progress.

[22]  Hans Clevers,et al.  The cancer stem cell: premises, promises and challenges , 2011, Nature Medicine.

[23]  T. Sørlie,et al.  Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome , 2008, The Journal of pathology.

[24]  Mark Shackleton,et al.  Efficient tumour formation by single human melanoma cells , 2008 .

[25]  H. Kleinman,et al.  A synthetic peptide containing the IKVAV sequence from the A chain of laminin mediates cell attachment, migration, and neurite outgrowth. , 1989, The Journal of biological chemistry.

[26]  Sangeeta N. Bhatia,et al.  A combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasis , 2012, Nature Communications.

[27]  Ying E Zhang,et al.  Non-Smad pathways in TGF-β signaling , 2009, Cell Research.

[28]  Erkki Ruoslahti,et al.  Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule , 1984, Nature.

[29]  Eric H. Nguyen,et al.  Differential effects of a soluble or immobilized VEGFR-binding peptide. , 2012, Integrative biology : quantitative biosciences from nano to macro.

[30]  J. Engelhardt,et al.  Aggressive melanoma cells escape from BMP7-mediated autocrine growth inhibition through coordinated Noggin upregulation , 2008, Laboratory Investigation.

[31]  Lauren E. Jansen,et al.  A cell-ECM screening method to predict breast cancer metastasis. , 2015, Integrative biology : quantitative biosciences from nano to macro.

[32]  K. Kilian,et al.  Directing stem cell fate by controlling the affinity and density of ligand-receptor interactions at the biomaterials interface. , 2012, Angewandte Chemie.

[33]  Daniel G. Anderson,et al.  Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cells , 2004, Nature Biotechnology.

[34]  Irving L. Weissman,et al.  Human Melanoma Initiating Cells Express Neural Crest Nerve Growth Factor Receptor CD271 , 2010, Nature.

[35]  Zang Ai-hua,et al.  Stem Cells,Cancer and Cancer Stem Cells , 2005 .

[36]  S. Pinho,et al.  Glycosylation in cancer: mechanisms and clinical implications , 2015, Nature Reviews Cancer.

[37]  J. Quiles,et al.  Gene-expression profiles, tumor microenvironment, and cancer stem cells in breast cancer: latest advances towards an integrated approach. , 2010, Cancer treatment reviews.

[38]  A. Bosserhoff,et al.  Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. , 2005, Cancer research.

[39]  F. A. Bennett,et al.  Evidence for the location of a binding sequence for the alpha 2 beta 1 integrin of endothelial cells, in the beta 1 subunit of laminin. , 1995, The Biochemical journal.

[40]  R. Weinberg,et al.  Cancer stem cells: mirage or reality? , 2009, Nature Medicine.

[41]  Randall T Peterson,et al.  Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors. , 2008, Bioorganic & medicinal chemistry letters.

[42]  E. Jabbari,et al.  Effect of grafting RGD and BMP-2 protein-derived peptides to a hydrogel substrate on osteogenic differentiation of marrow stromal cells. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[43]  R. Bizios,et al.  Design and function of novel osteoblast-adhesive peptides for chemical modification of biomaterials. , 1998, Journal of biomedical materials research.

[44]  Anja Nohe,et al.  The Mode of Bone Morphogenetic Protein (BMP) Receptor Oligomerization Determines Different BMP-2 Signaling Pathways* , 2002, The Journal of Biological Chemistry.

[45]  W. Sadee,et al.  ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. , 2005, Cancer research.

[46]  P. Knaus,et al.  Recent advances in BMP receptor signaling. , 2009, Cytokine & growth factor reviews.

[47]  F. Rosso,et al.  From Cell–ECM interactions to tissue engineering , 2004, Journal of cellular physiology.

[48]  M. Lutolf,et al.  Artificial niche microarrays for probing single stem cell fate in high throughput , 2011, Nature Methods.

[49]  B. Thiers,et al.  Identification of cells initiating human melanomas , 2009 .

[50]  Jan Paul Medema,et al.  Cancer stem cells: The challenges ahead , 2013, Nature Cell Biology.

[51]  Ratmir Derda,et al.  Arrays for the combinatorial exploration of cell adhesion. , 2004, Journal of the American Chemical Society.

[52]  P. Dirks.  Cancer stem cells: Invitation to a second round , 2010, Nature.

[53]  M. Herlyn,et al.  Bone morphogenetic proteins in melanoma: Angel or devil? , 2005, Cancer and Metastasis Reviews.

[54]  P. Chevallier,et al.  RGD and BMP-2 mimetic peptide crosstalk enhances osteogenic commitment of human bone marrow stem cells. , 2016, Acta biomaterialia.

[55]  David A. Cheresh,et al.  Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.

[56]  N. Katsanis,et al.  Novel bone morphogenetic protein signaling through Smad2 and Smad3 to regulate cancer progression and development , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[57]  J. Turnbull,et al.  Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. , 2011, The Journal of endocrinology.

[58]  Lucia R Languino,et al.  The integrin—growth factor receptor duet , 2007, Journal of cellular physiology.

[59]  Shelly Maman,et al.  The role played by the microenvironment in site-specific metastasis. , 2014, Cancer letters.

[60]  Irving L. Weissman,et al.  Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271 , 2011, Nature.

[61]  S. Morrison,et al.  Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. , 2010, Cancer cell.

[62]  J. Steele,et al.  Role of the heparin binding domain of fibronectin in attachment and spreading of human bone-derived cells. , 1995, Journal of cell science.

[63]  A. Regev,et al.  An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors , 2008, Nature Genetics.

[64]  J. McCarthy,et al.  Human fibronectin contains distinct adhesion- and motility-promoting domains for metastatic melanoma cells , 1986, The Journal of cell biology.

[65]  Ratmir Derda,et al.  High-throughput discovery of synthetic surfaces that support proliferation of pluripotent cells. , 2010, Journal of the American Chemical Society.

[66]  H. M. Jamil,et al.  TGF-β/BMP signaling and other molecular events: regulation of osteoblastogenesis and bone formation , 2015, Bone Research.

[67]  N. Carragher.  Profiling distinct mechanisms of tumour invasion for drug discovery: imaging adhesion, signalling and matrix turnover , 2009, Clinical & Experimental Metastasis.